Filing Details

Accession Number:
0001182489-11-000029
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-01-10 18:27:43
Reporting Period:
2011-01-06
Filing Date:
2011-01-10
Accepted Time:
2011-01-10 18:27:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1006195 Matrixx Initiatives Inc MTXX Pharmaceutical Preparations (2834) 870482806
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1087378 Collectors' Fund, L.p. C/O Porter Orlin Llc
666 Fifth Avenue, Suite 3403
New York NY 10103
No No Yes Yes
1120329 Alex A Porter C/O Porter Orlin Llc
666 Fifth Avenue, Suite 3403
New York NY 10103
No No Yes Yes
1221176 E Paul Orlin C/O Porter Orlin Llc
666 Fifth Avenue, Suite 3403
New York NY 10103
No No Yes Yes
1221177 Cf Advisors Llc C/O Porter Orlin Llc
666 Fifth Avenue, Suite 3403
New York NY 10103
No No Yes Yes
1279829 Amici Healthcare, L.p. C/O Porter Orlin Llc
666 Fifth Avenue, Suite 3403
New York NY 10103
No No Yes Yes
1326537 Porter Orlin Llc 666 Fifth Avenue,
Suite 3403
New York NY 10103
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2011-01-06 108,024 $8.63 765,424 No 4 P Direct
Common Stock, Par Value $0.001 Per Share Acquisiton 2011-01-06 16,800 $8.63 1,162,000 No 4 P Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect See Footnotes
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share 270,000 Direct
Common Stock, Par Value $0.001 Per Share 1,035,424 Indirect See Footnotes
Footnotes
  1. The entities and individuals identified in the footnotes of this Form 4 may be deemed members of a group holding equity securities of the Issuer. The filing of this Form 4 and any statements included herein shall not be deemed to be an admission that such entities and individuals are members of such group.
  2. The amount of securities shown in this row is owned directly by Amici Healthcare, L.P. ("Amici Healthcare").
  3. The amount of securities shown in this row is owned directly by The Collectors' Fund, L.P. (together with Amici Healthcare, the "Partnerships").
  4. The amount of securities shown in this row is, in the aggregate, owned directly by the Partnerships. As the general partner of each of the Partnerships, CF Advisors, LLC (the "General Partner") may be deemed to be a beneficial owner of the Issuer's securities held by each of the Partnerships. The General Partner disclaims any beneficial ownership of any of the Issuer's securities reported or referred to herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise, except as to securities representing the General Partner's pro rata interest in, and interest in the profits of, the Partnerships.
  5. The amount of securities shown in this row is, in the aggregate, owned directly by the Partnerships and a discretionary account (the "Managed Account") managed by Porter Orlin LLC (the "Investment Manager").
  6. As the registered investment adviser to the Partnerships and the Managed Account, the Investment Manager may be deemed to be a beneficial owner of the Issuer's securities held by the Partnerships and the Managed Account. The Investment Manager disclaims any beneficial ownership of any of the Issuer's securities reported or referred to herein for purposes of Section 16 of the Exchange Act or otherwise, except to the extent of its pecuniary interest, if any.
  7. Each of A. Alex Porter and Paul E. Orlin (collectively, the "Managing Members"), as a managing member of the General Partner and the Investment Manager with the power to exercise investment discretion, may be deemed to be a beneficial owner of the Issuer's securities held by the Partnerships and the Managed Account. Each of the Managing Members disclaims any beneficial ownership of any of the Issuer's securities reported or referred to herein for purposes of Section 16 of the Exchange Act or otherwise, except to the extent of his pecuniary interest, if any.